Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. [electronic resource]
Producer: 20160126Description: 390-404 p. digitalISSN:- 2211-1247
- Antineoplastic Agents -- pharmacology
- Blotting, Western
- Breast Neoplasms -- metabolism
- Cell Line, Tumor
- Drug Resistance, Neoplasm -- physiology
- Female
- Humans
- Lapatinib
- Mass Spectrometry
- Oligonucleotide Array Sequence Analysis
- Polymerase Chain Reaction
- Protein Kinase Inhibitors -- pharmacology
- Proteomics
- Quinazolines -- pharmacology
- Receptor, ErbB-2 -- metabolism
- Signal Transduction -- physiology
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.